Evidence map›Paper›PMID 26358730›Full record

ArticleBioinformatics (Oxford, England)2016

Inferred miRNA activity identifies miRNA-mediated regulatory networks underlying multiple cancers.

Eunjee Lee, Koichi Ito, Yong Zhao, Eric E Schadt, Hanna Y Irie, Jun Zhu

Open access · bronzeAbstract read
In one paragraph

Article in Bioinformatics (Oxford, England), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
1.9field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Review
  2. Article
  3. PmliHFM: Predicting Plant miRNA-lncRNA Interactions with Hybrid Feature Mining Network.Interdisciplinary sciences, computational life sciences · 2023
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Novel Predictors of Breast Cancer Survival Derived from miRNA Activity Analysis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2018
    Article
  16. Treatment-associatedOncotarget · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Eunjee LeeDepartment of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology.
Koichi ItoDepartment of Medicine, Hematology and Medical Oncology and.
Yong ZhaoDepartment of Genetics and Genomic Sciences.
Eric E SchadtDepartment of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Hanna Y IrieDepartment of Medicine, Hematology and Medical Oncology and The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Jun ZhuDepartment of Genetics and Genomic Sciences, Icahn Institute of Genomics and Multiscale Biology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Icahn School of Medicine at Mount Sinai · USPediatrics and Genetics · USGenomics (United Kingdom) · GB

Funding

Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's DiseaseU01AG046170 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI WANG, MINGHUI, ZHANG, BIN · 2013 to 2022
$26.0M
The Mount Sinai Transdisciplinary Center on Early Environmental ExposuresP30ES023515 · NIEHS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Maria Jose Rosa · 2014 to 2026
$21.3M
MicroRNA & Breast Cancer: Functional Characterization in a Population-Based StudyR01CA172460 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI CHEN, JIA · 2013 to 2017
$3.2M
Lung Adenocarcinoma Invasion GenomicsR01CA163772 · NCI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI MASSION, PIERRE P., POWELL, CHARLES A. · 2013 to 2017
$2.9M
Transforming Genomics with 5 PB Big Omics Data Engine Cray CS300-AC SupercomputerS10OD018522 · OD · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI KOVATCH, PATRICIA · 2014 to 2014
$1.9M
Developing methods for curating multi-omics dataU01HG008451 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI ZHU, JUN · 2015 to 2017
$1.5M
NCI NIH HHS CA163772NCI NIH HHS CA172460NCI NIH HHS R01 CA172460NHGRI NIH HHS HG008451NHGRI NIH HHS U01 HG008451NIA NIH HHS AG046170NIEHS NIH HHS P30 ES023515NIH HHS S10 OD018522
6 · The paper itself

Abstract

motivationMicroRNAs (miRNAs) play a key role in regulating tumor progression and metastasis. Identifying key miRNAs, defined by their functional activities, can provide a deeper understanding of biology of miRNAs in cancer. However, miRNA expression level cannot accurately reflect miRNA activity.

resultsWe developed a computational approach, ActMiR, for identifying active miRNAs and miRNA-mediated regulatory mechanisms. Applying ActMiR to four cancer datasets in The Cancer Genome Atlas (TCGA), we showed that (i) miRNA activity was tumor subtype specific; (ii) genes correlated with inferred miRNA activities were more likely to enrich for miRNA binding motifs; (iii) expression levels of these genes and inferred miRNA activities were more likely to be negatively correlated. For the four cancer types in TCGA we identified 77-229 key miRNAs for each cancer subtype and annotated their biological functions. The miRNA-target pairs, predicted by our ActMiR algorithm but not by correlation of miRNA expression levels, were experimentally validated. The functional activities of key miRNAs were further demonstrated to be associated with clinical outcomes for other cancer types using independent datasets. For ER(-)/HER2(-) breast cancers, we identified activities of key miRNAs let-7d and miR-18a as potential prognostic markers and validated them in two independent ER(-)/HER2(-) breast cancer datasets. Our work provides a novel scheme to facilitate our understanding of miRNA. In summary, inferred activity of key miRNA provided a functional link to its mediated regulatory network, and can be used to robustly predict patient's survival. AVAILABILITY AND IMPLEMENTATION: the software is freely available at http://research.mssm.edu/integrative-network-biology/Software.html. CONTACT: jun.zhu@mssm.edu SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

Indexed as

Gene Regulatory NetworksBreast NeoplasmsCell Line, TumorCohort StudiesFemaleGene Expression Regulation, NeoplasticHumansMicroRNAsMolecular Sequence AnnotationNeoplasmsPrognosisReproducibility of ResultsRNA, MessengerSoftwareSurvival RateMicroRNAsRNA, Messenger

Identifiers

PMID26358730
PMCPMC5006235
OpenAlexW2127688799

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.